These modifications result in reduced α8β1 expression, contributing to shorter survival times, alterations in tumor microenvironment, and activation of key signaling pathways such as PI3k/AKT/mTOR, which promote tumor proliferation, invasion, and metastasis [34]. The gene discussed is AKT1; the disease is neoplasm.